Systemic therapy for bladder cancer finally comes into a new age
نویسندگان
چکیده
منابع مشابه
Glycoscience finally comes of age.
Glycoscience—the study of the complex carbohydrates on the surface of proteins and lipids—has long been the neglected stepchild of molecular biology. Although genomics, proteomics and now systems biology have become hot topics of biomedical research, attracting both researchers and funding, glycoscience has played a rather minor role. Once of little interest to understanding biology on a larger...
متن کاملFireWire Finally Comes Home
117 Standards I n February 1997, I wrote a Computer column titled " Linking Computers and Consumer Electronics, " which described the IEEE 1394 networking standard, otherwise known as FireWire. FireWire was designed to link personal computers, digital cameras , televisions, DVD players, printers, and other home electronics equipment. In one sense, FireWire represented the technology behind all ...
متن کاملSystemic Therapy for Invasive Bladder Cancer.
BACKGROUND: Bladder cancer is one of the most common malignancies in Western society. In the United States, approximately 10,000 of these patients present with invasive disease, and more progress from superficial bladder cancer. METHODS: The authors review the literature on systemic treatment for both localized and metastatic bladder cancer, and they include their experience in defining approac...
متن کاملSystemic therapy for bladder cancer - a medical oncologist's perspective.
Advanced bladder cancer, both muscle-invasive localized disease and metastatic disease, is managed with systemic chemotherapy. Cisplatin-based multi-agent chemotherapy remains the cornerstone for systemic therapy. MVAC (methotrexate-vinblastine-doxorubicin-cisplatin) has been most rigorously studied, both neoadjuvantly and for palliation of metastatic disease. For metastatic disease, cisplatin-...
متن کاملCastration refractory prostate cancer: cinderella finally comes to the ball.
to show a definite clinical benefit is abiraterone acetate. Abiraterone acetate, and its active metabolite abiraterone, are potent, selective and irreversible inhibitors of CYP17 ahydroxylase and C17,20-lyase that catalyse two essential steps in androgen biosynthesis [6]. Abiraterone markedly decreases levels of androgens in CRPC and initial phase I and II clinical trials showed promising activ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Future Oncology
سال: 2016
ISSN: 1479-6694,1744-8301
DOI: 10.2217/fon-2016-0135